Advertisement

Thrombocytopenia in Intensive Care Patients

  • M. Levi
  • J. J. Hofstra
  • S. Opal

Abstract

Thrombocytopenia is a common feature in intensive care patients. Similar to other settings in which thrombocytopenia may occur, the decrease in platelet count may be caused by impaired production, increased consumption, or enhanced degradation of these cells. In this chapter, we will discuss the epidemiology and differential diagnosis of a decreased platelet count in critically ill patients, First, we will briefly introduce platelet function and platelet vessel wall interaction in the normal situation and during severe infection and/or inflammation.

Keywords

Disseminate Intravascular Coagulation Platelet Adhesion Thrombotic Thrombocytopenic Purpura Intensive Care Unit Mortality Intensive Care Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Levi M (2005) Platelets. Crit Care Med 33:S523–S525PubMedCrossRefGoogle Scholar
  2. 2.
    Hawiger JJ (1994) Adhesive interactions of blood cells and the vascular wall in hemostasis and thrombosis. In: Colman RW, Hirsh J, Marder VJ, Salzman EW (eds) Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 639–653Google Scholar
  3. 3.
    Ware JA, Heistad DD (1993) Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions. N Engl J Med 328:628–635PubMedCrossRefGoogle Scholar
  4. 4.
    Woodside DG, Liu S, Ginsberg MH (2001) Integrin activation. Thromb Haemost 86:316–323PubMedGoogle Scholar
  5. 5.
    Ruoslahti E (1991) Integrins. J Clin Invest 87:1–5PubMedCrossRefGoogle Scholar
  6. 6.
    Phillips DR, Prasad KS, Manganello J, Bao M, Nannizzi-Alaimo L (2001) Integrin tyrosine phosphorylation in platelet signaling. Curr Opin Cell Biol 13:546–554PubMedCrossRefGoogle Scholar
  7. 7.
    Clemens R, Pramoolsinsap C, Lorenz R, Pukrittayakamee S, Bock HL, White NJ (1994) Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol 87:100–105PubMedGoogle Scholar
  8. 8.
    Furie B, Furie BC, Flaumenhaft R (2001) A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 86:214–221PubMedGoogle Scholar
  9. 9.
    Shebuski RJ, Kilgore KS (2002) Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 300:729–735PubMedCrossRefGoogle Scholar
  10. 10.
    Romo GM, Dong JF, Schade AJ, et al (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803–814PubMedCrossRefGoogle Scholar
  11. 11.
    Simon DI, Chen Z, Xu H, et al (2000) Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 192:193–204PubMedCrossRefGoogle Scholar
  12. 12.
    Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ (1999) The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 274:29019–29024PubMedCrossRefGoogle Scholar
  13. 13.
    Silverstein RL, Asch AS, Nachman RL (1989) Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest 84:546–552PubMedGoogle Scholar
  14. 14.
    Ruggeri ZM (2002) Platelets in atherothrombosis. Nat Med 8:1227–1234PubMedCrossRefGoogle Scholar
  15. 15.
    Ruggeri ZM (2003) Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 1:1335–1342PubMedCrossRefGoogle Scholar
  16. 16.
    Arya M, Anvari B, Romo GM, et al (2002) Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 99:3971–3977PubMedCrossRefGoogle Scholar
  17. 17.
    Jung SM, Moroi M (2000) Activation of the platelet collagen receptor integrin alpha(2) beta(l): its mechanism and participation in the physiological functions of platelets. Trends Cardiovasc Med 10:285–292PubMedCrossRefGoogle Scholar
  18. 18.
    Massberg S, Konrad I, Bultmann A, et al (2003) Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J 18:397–399PubMedGoogle Scholar
  19. 19.
    Clemetson KJ, Clemetson JM (2001) Platelet collagen receptors. Thromb Haemost 86:189–197PubMedGoogle Scholar
  20. 20.
    Jurk K, Clemetson KJ, De Groot PG, et al (2003) Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 17:1490–1492PubMedGoogle Scholar
  21. 21.
    Roberts DD, Sherwood JA, Spitalnik SL, et al (1985) Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature 318:64–66PubMedCrossRefGoogle Scholar
  22. 22.
    Brittain JE, Mlinar KJ, Anderson CS, Orringer EP, Parise LV (2001) Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction. J Clin Invest 107:1555–1562PubMedGoogle Scholar
  23. 23.
    Ill CR, Engvall E, Ruoslahti E (1984) Adhesion of platelets to laminin in the absence of activation. J Cell Biol 99:2140–2145PubMedCrossRefGoogle Scholar
  24. 24.
    Thiagarajan P, Kelly KL (1988) Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 263:3035–3038PubMedGoogle Scholar
  25. 25.
    Levi M, Opal SM (2006) Coagulation abnormalities in critically ill patients. Crit Care 10: 222–228PubMedCrossRefGoogle Scholar
  26. 26.
    Vanderschueren S, De Weerdt A, Malbrain M, et al (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871–1876PubMedCrossRefGoogle Scholar
  27. 27.
    Baughman RP, Lower EE, Flessa HC, Tollerud DJ (1993) Thrombocytopenia in the intensive care unit. Chest 104:1243–1247PubMedGoogle Scholar
  28. 28.
    Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG (2002) Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30:1765–1771PubMedCrossRefGoogle Scholar
  29. 29.
    Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A (1999) Thrombocytopenia in a surgical ICU. Chest 115:1363–1370PubMedCrossRefGoogle Scholar
  30. 30.
    Hanes SD, Quarles DA, Boucher BA (1997) Incidence and risk factors of thrombocytopenia in critically ill trauma patients. Ann Pharmacother 31:285–289PubMedGoogle Scholar
  31. 31.
    Akca S, Haji Michael P, de Medonca A, Suter PM, Levi M, Vincent JL (2002) The time course of platelet counts in critically ill patients. Crit Care Med 30:753–756PubMedCrossRefGoogle Scholar
  32. 32.
    Oppenheim-Eden A, Glantz L, Eidelman LA, Sprung CL (1999) Spontaneous intracerebral hemorrhage in critically ill patients: incidence over six years and associated factors. Intensive Care Med 25:63–67PubMedCrossRefGoogle Scholar
  33. 33.
    Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28:451–457PubMedCrossRefGoogle Scholar
  34. 34.
    Levi M (2005) Platelets in sepsis. Hematology 10(Suppl 1):129–131PubMedCrossRefGoogle Scholar
  35. 35.
    Folman CC, Linthorst GE, van Mourik J, et al (2000) Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis? Thromb Haemost 83:923–930PubMedGoogle Scholar
  36. 36.
    Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H (1997) Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103:114–120PubMedCrossRefGoogle Scholar
  37. 37.
    Warkentin TE, Aird WC, Rand JH (2003) Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program 497–519Google Scholar
  38. 38.
    Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341: 586–592PubMedCrossRefGoogle Scholar
  39. 39.
    Taylor FBJ, Toh CH, Hoots WK, Wada H, Levi M (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330PubMedGoogle Scholar
  40. 40.
    Bakhtiari K, Meijers JC, de Jonge E, Levi M (2004) Prospective validation of the international society of thrombosis and maemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32:2416–2421PubMedCrossRefGoogle Scholar
  41. 41.
    Dhainaut JF, Yan SB, Joyce DE, et al (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2:1924–1933PubMedCrossRefGoogle Scholar
  42. 42.
    Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347:589–600PubMedCrossRefGoogle Scholar
  43. 43.
    Tsai HM (2003) Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura. Arterioscler Thromb Vasc Biol 23:388–396PubMedCrossRefGoogle Scholar
  44. 44.
    Verma AK, Levine M, Shalansky SJ, Carter CJ, Kelton JG (2003) Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy 23:745–753PubMedCrossRefGoogle Scholar
  45. 45.
    Warkentin TE, Levine MN, Hirsh J, et al (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332:1330–1335PubMedCrossRefGoogle Scholar
  46. 46.
    Warkentin TE (2003) Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121:535–555PubMedCrossRefGoogle Scholar
  47. 47.
    Sheridan D, Carter C, Kelton JG (1986) A diagnostic test for heparin-induced thrombocytopenia. Blood 67:27–30PubMedGoogle Scholar
  48. 48.
    Makoni SN (2001) Acute profound thrombocytopenia following angioplasty: the dilemma in the management and a review of the literature. Heart 86:18e–CrossRefGoogle Scholar
  49. 49.
    Hirsh J, Heddle N, Kelton JG (2004) Treatment of heparin-induced thrombocytopenia: A critical review. Arch Intern Med 164:361–369PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2007

Authors and Affiliations

  • M. Levi
    • 1
  • J. J. Hofstra
    • 2
  • S. Opal
    • 3
  1. 1.Department of Internal MedicineAcademic Medical CenterAmsterdamNetherlands
  2. 2.Department of Intensive CareAcademic Medical CenterAmsterdamNetherlands
  3. 3.Infectious Disease DivisionBrown Medical SchoolPawtucketUSA

Personalised recommendations